+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
FEMALE
ID07076186

Decentralized Phase II Trial of Adjuvant Doxorubicin and Trabectedin Chemotherapy for Patients With Uterine Leiomyosarcoma

Led by M.D. Anderson Cancer Center · Updated on 2026-10-13

48

Participants Needed

1

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether standard chemotherapy with doxorubicin and trabectedin can improve cancer-free survival in patients with Stage 1b, 2, and 3 uterine leiomyosarcoma who have had surgery that completely removed their tumors. This Phase II trial focuses on patients at high risk of relapse and aims to assess disease-free survival, overall survival, treatment-related side effects, and quality of life. The study also explores genetic factors, treatment response markers, and the feasibility of a decentralized trial approach. Participants will receive six cycles of adjuvant chemotherapy with doxorubicin and trabectedin delivered by intravenous infusion on an outpatient basis. The trial uses a single-arm design where all participants receive this standard-of-care chemotherapy. The study also examines patient satisfaction and compares protocol adherence and safety monitoring between centralized and decentralized trial participation. During the study, participants will undergo regular monitoring for safety and adverse events for about one year. Assessments include imaging scans to confirm no residual disease, organ and marrow function tests, and patient-reported quality of life measures. The trial collects blood samples to analyze circulating tumor DNA and genetic alterations. Participants are followed to evaluate treatment toxicity, survival outcomes, and adherence to the chemotherapy protocol throughout the study duration.

CONDITIONS

Brief Title

Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMS

Research Team

E

Elise Nassif Haddad, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here